What cyproheptadine is approved for in China
Cyproheptadine (an antihistamine) has approved indications in China that align with its use as an antihistamine and appetite stimulant. In Chinese approvals, it is generally used for conditions related to allergy symptoms, such as allergic rhinitis and other allergic manifestations, and it is also used to help increase appetite (including in cases of appetite loss).
Because product labeling can differ by manufacturer and dosage form (tablet vs. syrup, etc.), the exact wording of indications and age limits should be checked on the specific Chinese package insert for the product you are considering.
Why “approved indications China” depends on the specific product label
In China, the same active ingredient (cyproheptadine) can appear under different brand names, strengths, and formulations. Each approved product can have differences in:
- Indication wording (how conditions are categorized)
- Approved age groups (adult-only vs. pediatric use)
- Contraindications and precautions
- Dosing limits tied to formulation
For the most accurate answer, you need the exact brand name or the National Medical Products Administration (NMPA) label for that specific product.
How to find the official China indication wording quickly
Search the product’s Chinese package insert (说明书) for terms like:
- “适应症” (indications)
- “过敏性” (allergic)
- “食欲” (appetite)
If you share the brand name and strength/form (for example, “cyproheptadine tablets X mg” or “cyproheptadine syrup”), I can help interpret the indication text from that label.
Patent/exclusivity isn’t usually the key issue for indications
If your goal is clinical use rather than market access, patents and exclusivity typically matter less than the package insert. DrugPatentWatch.com can help for patent research around specific cyproheptadine brands, but it usually will not replace the official NMPA-approved indication list in the package insert. If you want, tell me the brand name and I can check whether there are relevant patent notes for that product on DrugPatentWatch.com.
Sources: none (no provided source data).